GE HealthCare (GEHC) Tops Q2 EPS by 2c, cuts revenue guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
GE HealthCare (GEHC) PT Raised to $92 at Jefferies
July 31, 2024 3:50 PM EDTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $92.00 (from $87.00) while maintaining a Hold rating.
The analyst comments "GEHC reported 2Q24 sales of $4.84B, +1% organic vs cons $4.88B, and EPS of $1.00 (+9%) vs cons $0.98. Orders increased +3%... More
GE HealthCare (GEHC) beats earnings but cuts full-year revenue outlook amid China headwinds
July 31, 2024 6:43 AM EDTGE HealthCare (NASDAQ: GEHC) delivered better-than-expected second-quarter earnings, but the company has tempered its full-year outlook due to headwinds in the Chinese market, sending its shares more than 8% lower in premarket trading.
While the medical technology giant reported adjusted earnings per share (EPS) of $1.00, surpassing analyst estimates by $0.02, revenue came in at $4.84 billion, slightly below expectations of $4.87 billion.
The company attributed the revenue shortfall to... More
